BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND WT1, WAGR, 7490, ENSG00000184937, WT33, GUD, WIT-2 AND Treatment
39 results:

  • 1. Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium.
    Van Genechten T; De Laere M; Van den Bossche J; Stein B; De Rycke K; Deschepper C; Hazes K; Peeters R; Couttenye MM; Van De Walle K; Roelant E; Maes S; Vanden Bossche S; Dekeyzer S; Huizing M; Caluwaert K; Nijs G; Cools N; Verlooy J; Norga K; Verhulst S; Anguille S; Berneman Z; Lion E
    BMJ Open; 2024 Mar; 14(3):e077613. PubMed ID: 38503417
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Predicting the prognosis of glioma patients with TERT promoter mutations and guiding the specific immune profile of immune checkpoint blockade therapy.
    Cao W; Lan J; Hu C; Kong J; Xiang L; Zhang Z; Sun Y; Zeng Z; Lei S
    Aging (Albany NY); 2024 Mar; 16(6):5618-5633. PubMed ID: 38499392
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. An immune signature to predict the prognosis of
    Cao W; Sun P; Luo S; Zeng Z; Xiao C; Yu W; Lei S
    Aging (Albany NY); 2023 Oct; 15(19):10453-10472. PubMed ID: 37812190
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Uterine choriocarcinoma coexistence with endometroid adenocacinoma: a case report and literature review.
    Bai L; Chen Y; Han L; Zheng A; Mo X
    BMC Womens Health; 2023 May; 23(1):252. PubMed ID: 37165420
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Locally advanced choroidal melanoma with favorable molecular prognosis - case report.
    Bălăşoiu AT; Ştefănescu-Dima AŞ; Bălăşoiu M; Ciurea RN; Muraru A; Dan AO; Simionescu CE
    Rom J Morphol Embryol; 2022; 63(4):645-652. PubMed ID: 36808200
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A case of ovarian Teratoma with nephroblastoma presenting abdomen metastasis.
    Wu Y; Chu C; Zhang J; Nitish B; Ni J; Xu X
    J Clin Lab Anal; 2022 May; 36(5):e24364. PubMed ID: 35349728
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Maintenance of wt1 expression in tumor cells is associated with a good prognosis in malignant glioma patients treated with wt1 peptide vaccine immunotherapy.
    Yokota C; Kagawa N; Takano K; Chiba Y; Kinoshita M; Kijima N; Oji Y; Oka Y; Sugiyama H; Tsuboi A; Izumoto S; Kishima H; Hashimoto N
    Cancer Immunol Immunother; 2022 Jan; 71(1):189-201. PubMed ID: 34089373
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Branched Multipeptide-combined Adjuvants Potentially Improve the Antitumor Effects on Glioblastoma.
    Tran TA; Kim YH; Jung S; Kim IY; Moon KS; Jang WY; Lee HJ; Lee JJ; Jung TY
    J Immunother; 2021 May; 44(4):151-161. PubMed ID: 33512855
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Long Noncoding RNA wt1-AS Inhibit cell Malignancy via miR-494-3p in Glioma.
    Qiu G; Tong W; Jiang C; Xie Q; Zou J; Luo C; Zhao J; Zhang L; Zhao J
    Technol Cancer Res Treat; 2020; 19():1533033820919759. PubMed ID: 32419643
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Immune adjuvant therapy using Bacillus Calmette-Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments.
    Nishida S; Tsuboi A; Tanemura A; Ito T; Nakajima H; Shirakata T; Morimoto S; Fujiki F; Hosen N; Oji Y; Kumanogoh A; Kawase I; Oka Y; Azuma I; Morita S; Sugiyama H
    Medicine (Baltimore); 2019 Aug; 98(33):e16771. PubMed ID: 31415377
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Differential Expression of Wilms' tumor Protein in Diffuse Intrinsic Pontine Glioma.
    Lee S; Kambhampati M; Yadavilli S; Gordish-Dressman H; Santi M; Cruz CR; Packer RJ; Almira-Suarez MI; Hwang EI; Nazarian J
    J Neuropathol Exp Neurol; 2019 May; 78(5):380-388. PubMed ID: 30990879
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Selective Inhibition of HIF1α Expression by ZnSO
    Burián Z; Ladányi A; Barbai T; Piurkó V; Garay T; Rásó E; Tímár J
    Pathol Oncol Res; 2020 Apr; 26(2):673-679. PubMed ID: 30613921
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Histopathology and clinical aspects of extrauterine pregnancy].
    Horn LC; Opitz S; Handzel R; Brambs CE
    Pathologe; 2018 Sep; 39(5):431-444. PubMed ID: 30135973
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Pathologic features on gonadal changes of sexual developmental disorders in children].
    Yi P; Niu HL; Gao Q; Wang FH; Jia W; Chen ZR; Xia JQ; Li LP; Cao Y; Zeng RX
    Zhonghua Bing Li Xue Za Zhi; 2018 Jul; 47(7):531-535. PubMed ID: 29996319
    [No Abstract]    [Full Text] [Related]  

  • 15. Chemosensitivity of BRCA1-Mutated Ovarian Cancer cells and Established Cytotoxic Agents.
    van Haaften C; van Eendenburg J; Boot A; Corver WE; Haans L; van Wezel T; Trimbos JB
    Int J Gynecol Cancer; 2017 Oct; 27(8):1571-1578. PubMed ID: 28604461
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma.
    Akasaki Y; Kikuchi T; Homma S; Koido S; Ohkusa T; Tasaki T; Hayashi K; Komita H; Watanabe N; Suzuki Y; Yamamoto Y; Mori R; Arai T; Tanaka T; Joki T; Yanagisawa T; Murayama Y
    Cancer Immunol Immunother; 2016 Dec; 65(12):1499-1509. PubMed ID: 27688162
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Progress in the molecular genetic mechanism of gonadoblastoma].
    Yu LL; Dong WR; Chen MH; Kong XY
    Yi Chuan; 2015 Nov; 37(11):1105-15. PubMed ID: 26582524
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Wilms tumor 1 gene, CD97, and the emerging biogenetic profile of glioblastoma.
    Somasundaram A; Ardanowski N; Opalak CF; Fillmore HL; Chidambaram A; Broaddus WC
    Neurosurg Focus; 2014 Dec; 37(6):E14. PubMed ID: 25434383
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A subtraction tolerization method of immunization allowed for Wilms' tumor protein-1 (wt1) identification in melanoma and discovery of an antitumor peptide sequence.
    Massaoka MH; Matsuo AL; Figueiredo CR; Girola N; Farias CF; Pasqualoto K; Travassos LR
    J Immunol Methods; 2014 Dec; 414():11-9. PubMed ID: 25205401
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Methylation-specific multiplex ligation-dependent probe amplification identifies promoter methylation events associated with survival in glioblastoma.
    Rankeillor KL; Cairns DA; Loughrey C; Short SC; Chumas P; Ismail A; Chakrabarty A; Lawler SE; Roberts P
    J Neurooncol; 2014 Apr; 117(2):243-51. PubMed ID: 24554053
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.